Molecular, cellular, and functional properties of bone marrow T lymphocyte progenitor clones [published erratum appears in J Exp Med 1988 Jun 1;167(6):2023] by unknown
Precursor cells from fetal liver and bone marrow colonize the thymus at day
11-12 of gestation, and the thymic microenvironment influences differentiation
of the precursor cells along the T lymphocyte pathway (1-3) . It is not known
whether the colonizing precursor cell is a totipotential stem cell capable of giving
rise to all types ofblood cells, a common lymphoid stem cell incapable of myeloid
differentiation but still able to generate both B andT cell lineages, ora restricted
progenitor that is committed toT lymphopoiesis . While some evidence suggests
the existence of totipotential stem cells (1-5), there is no direct proof that a
common lymphoid stem cell or a T lymphocyte lineage-restricted progenitor
(Pro-T lymphocyte) exists . Indeed, with the exception of B lineage-restricted
progenitor cells (Pro-B lymphocytes) (6), self-renewing clones of the other
putative progenitor cells have so far not been obtained in vitro .
The T cell receptor for recognition of antigen is a heterodimeric transmem-
brane glycoprotein consisting of disulfide-linked a and # subunits of molecular
weight 40-50 x 10' eachand the genes encoding these proteins were cloned (7-
10) . A third T cell-specific gene called 7 was found (11, 12); the function of its
products is still unknown . Mature functionally competent helper and cytotoxic
T cells can develop with or without productive rearrangement at the .y locus
(13) .
Using heterogenous populations of thymocytes, it was found that embryonic
thymocytes at day 15 of gestation start to rearrange D to J segments of the ,0
gene complex.mRNA fora and a chains could be detected at day 17 of gestation
when surface molecules with characteristics of a/,B heterodimers began to be
detectable on the cell membrane (14-16) . The 'y gene is transcriptionally active
in the thymus at day 14 of gestation, reaches a peak steady-state level at day 15,
and declines thereafter (12, 14) .
By applying a criteria similar to that used for delineating the stages of B cell
development, we call a cell that has both the a and the (3 chain genes in the
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germline configuration and gives rise only to mature T lymphocytes, a Pro-T
lymphocyte; and we call a cell that has rearranged one of its a or ,3 antigen-
receptor genes and does not express T cell antigen-receptor on the cell mem-
brane, a pre-T cell.
An ideal way of studying T cell development and the process of intrathymic
differentiation is to establish Pro- and pre-T cell clones and follow their
differentiation both in vivo and in vitro. Here we describe the establishment of
continuous proliferating bone marrow clones whose cellular and molecular
properties fit the criteria of Pro-T lymphocytes .
Materials and Methods
Materials. We used the following materials: PMA (Sigma Chemical Co., St. Louis,
MO), LPS (Difco Laboratories Inc., Detroit, MI), Dextran-sulfate (DxS;' Pharmacia Fine
Chemicals, Piscataway, NJ), Iscove's Dulbecco's modified medium (IMDM; Gibco Labo-
ratories, Grand Island, NY), FCS (Boehringer Mannheim Biochemicals, Mannheim,
Federal Republic of Germany), 5-Azacytidine (5-Aza; Sigma Chemical Co.), Retinoic acid
(Sigma Chemical Co.), Ionomycin (Iono; Calbiochem-Behring Corp., LaJolla, CA), DMSO
(Sigma Chemical Co.), low toxic rabbit complement (Cedarlane Laboratories Ltd., On-
tario, Canada), ['H]thymidine (TRA 120; The Radiochemical Centre, Amersham Corp.,
Amersham, United Kingdom).
Mice.
￿
CBA/J, C3H/Hej, C57BL/6, DBA/2, ATH, and B10 .A (4R) mice were from
our animal facilities. Breeding pairs of CBA/N-t/nu and NIH Swiss II nu/nu mice were a
gift of Dr. W . E. Paul (National Institute of Allergy and Infectious Diseases, Bethesda,
MD). The CBA/N-nu/nu congenic strain, which carries both xid and nu mutations, was
raised by a breeding strategy recommended by Azar and colleagues (17). The severe
combined immunodeficiency (SLID) mutation occurred in the C.B.-17/lcr (C.B.-17)
inbred strain (18). Breeding pairs of C.B.-17 SCID mice were donated by Dr. M . Bosma
(Institute for Cancer Research, Philadelphia, PA) to our Institute. All mice are bred and
maintained under pathogen-free conditions in the mouse barrier facility of our Institute
and were housed in sterile isolators. All mice were 5-10-wk-old males or females at the
time of study.
Monoclonal Antibodies.
￿
mAbs against the following surface antigens were used: Ly-1
(53-7-313), Lyt-2 (53-63-72, 3168.81, 3.155), L3T4 (GK1 .5, H-129 .19, RL-172), Thy-
1 .2 (jlj), Thy-1 .1 (19E12,), jiid, Mac-l (M1/70 .15 .11), PgP-1 (142/5), IL-2-R (PC61, 7134),
antibody specific for IL-3-sensitive mouse cells (CC 11), anti-mouse granulocytes (GM1 .2;
New England Nuclear, Boston, MA), B-220 (14.8, RA3-3A1/6B1), la (M5/114.15.2,
10.2 .16), Lyb-2 .1 (IO.I.D2). The reports describing the characteristics of all these mAbs
are listed elsewhere (6, 19-21).
mAbs 19E12, PC61, CC11, and 10.1.132 were purified from hybridoma culture super-
natants by affinity chromatography using protein A-Sepharose (Pharmacia Fine Chemi-
cals) columns and were conjugated to biotin-N-hydroxisuccinimide (Calbiochem-Behring
Corp.) as described (20). FITC-conjugated anti-Thy-1 .2 mAb was purchased from New
England Nuclear; FITC-labeled avidin was from Becton Dickinson & Co., Mountain View,
CA; FITC-conjugated rabbit anti-mouse IgM was from Cappel Laboratories, Cochran-
ville, PA; and FITC-conjugated sheep anti-mouse Ig that crossreacts with rat Ig was a
generous gift of L. Forni (Basel Institute for Immunology).
Cytokines.
￿
Recombinant human IL-2 (22), recombinant mouse IL-3 (23), recombinant
human IL-1 were from Cistrom Technologies (Boston, MA); purified IL-3 and granulo-
cyte/macrophage colony-stimulating factor (GM/CSF) were purchased from Genzyme
(Suffolk, England); recombinant mouse IL-4/B cell stimulatory factor 1 (BSF-1) (24) was
a gift of Dr. P. Sideras (University of Stockholm, Stockholm, Sweden); synthetically
' Abbreviations used in this paper:
￿
5-Aza, 5-Azacytidine; BSF-1, B cell stimulatory factor 1; CM,
culture medium; DxS, dextran-sulfate; GM/CSF, granulocyte/macrophage colony-stimulating factor;
IMDM, Iscove's Dulbecco's modified medium; SCID, severe combined immunodeficiency.14
￿
PRO-T LYMPHOCYTE CLONES
purified thymulin was a gift of Drs. M. Dardene and J. F. Bach (Hospital Necker, Paris,
France).
Establishment of the C4 Line In Vitro.
￿
Bone marrow cell suspensions were obtained
from CBA/N X NIH Swiss nu/nu male mice as described (25). The cells were exposed to
a mixture of cytotoxic mAbs (j11d, M5/114, 10.2.16, GM 1 .2, and RA3-3A1/6B1) and
rabbit complement treatment (20). After two cycles of treatment, viable cellswere washed
three times in culture medium (CM; IMDM + 2.5% FCS + 1 % human AB serum + 5 X
10-5 2-ME + 50 wg/ml gentamycin). The above procedure usually killed 93-98% of bone
marrow cells. Viable cells were suspended in CM supplemented with IL-3-containing
supernatants obtained from WEHI-3 cells as described (25), and supernatants obtained
from Con A-stimulated mouse spleen cells (26) (final concentration 10%). Optimal
concentrations of WEHI-3 supernatants were determined on the IL-3-dependent CB/Bm7
pro-B lymphocyte clone (6). Altogether, this CM is referred to as growth factor-
conditioned medium (GFCM). Viable bone marrow cells (10') obtained as detailed above,
suspended in 0.5 ml of GFCM, were cultured in Linbro tissue culture plates (Flow
Laboratories, Irvine, Scotland) at 37° C for 4-5 d. Every 3 d, half of the medium was
replaced with fresh GFCM. Confluent cultures were gently resuspended and split between
two wells, each receiving I ml of fresh GFCM per Linbro well. After ^-3-4 wk the cell
lines could be transferred to 50-ml tissue culture flasks (Nunc, Roskilde, Denmark).
Established cell lines can be harvested every 2 .5-3 d and diluted 1 :8 to 1 :10 with fresh
GFCM . Of the cell lines established, the C4 line was chosen for further study based on its
phenotype. The C4 line was established in culture in October 1984 and was cloned by
micromanipulation (25) in December 1984. The studies described here are those per-
formed with the C4-77, C4-86, and C4-95 clones. They have been maintained in CM
supplemented with IL-3-containing supernatants obtained from WEHI-3 cells (WEHI-
CM) since January 1985 up to the present. The C4 clones can be frozen by standard
procedures (25).
Immunofluorescence Staining and Flow Fluorometry Analysis (FACS).
￿
This was carried
out as described in detail elsewhere (20) using a FACS-I analyzer (Becton Dickinson &
Co.). Direct immunofluorescence staining was used for detection of Thy-1 .2 and surface
IgM. Indirect immunofluorescence staining was carried out using as second-step reagent
FITC-conjugated avidin and FITC-conjugated sheep anti-Ig as required. Dead cells were
excluded from analysis by propidium Iodide. Fluorescence emitted by single-viable cells
was measured using logarithmic amplification, the data collected from 10' cells were
analyzed with a program in a Consort 30 computer, and histograms were generated. Lyt-
2+ cells generated by the C4 clones in vitro (see below) were isolated by cell sorting with
a FACS 440 based on staining (anti-Lyt-2 53-6-72 mAb and FITC-labeled sheep anti-Ig
antibody) as described elsewhere (20).
Proliferative Responses to Cytokines.
￿
The cells were harvested in log phase of growth,
washed three times, and resuspended in CM . The cells (10') were incubated in microplate
wells in a final volume of 200,ul of CM containingthe followingagents: IL-3 (final dilution
1 to 20 U/ml), GM/CSF (10-100 U/ml), IL-2 (10-500 U/ml), IL-I (5-50 U/ml), the
combination of PMA (10 ng/ml) + Iono (500 ng/ml) and IL-2 (100 U/ml) plus or minus
IL-I (10 U/ml). The cultures in triplicate were incubated at 37'C for 24 and 48 h. Cell
growth was measured by both direct visualization of the cultures with an inverted
microscope and ['H]thymidine uptake (37 KBq/well) during the last 6 h of the culture
period. The data are expressed as counts per minute and are the mean of triplicate
samples.
Cell Surface Labeling, Immunoprecipitation, and SDS-PAGE Analysis.
￿
These procedures
were carried out as described (19) using PC61 and CC 11 mAbs coupled to CNBr-activated
Sepharose 4B in the immunoprecipitations.
IsolationandAnalysis ofNucleicAcids.
￿
DNA preparation, restriction enzyme digestions,
agarose gel electrophoresis, DNA blotting procedures, probe preparations, hybridization
procedures, and autoradiography were performed as described (10).
Chain Gene Complex Probes.
￿
The 4.1 cDNA probe specific for the constant region of
the 0 gene complex and the J15 probe specific for J(#2 were described elsewhere (15).PALACIOS ET AL.
￿
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a Chain Gene ComplexProbes.
￿
The genomic probes Bam 7.5 (a 1 .5-kb Bam HI fragment
from cosmid clone BDFL7.5), Bam 2.5 (a 2.3-kb Bam HI fragment from cosmid clone
BDFL2.5), and Kpn 7.5 (a 1 .7-kb Kpn I fragment from cosmid clone BDFL7.5) spanning
30, 10, and 40 kb, respectively, 5' to the a constant region (10) were used.
,y Gene ComplexProbes.
￿
The Ty5 cDNA specific probe for the constant regions of the
y gene complex (27) and the Jy I probe (1 .2-kb Ava I-Hind III genomic fragment) (13,
28) were used.
Transfer of the C4 Clones into Sublethally Irradiated Mice.
￿
C4-77, C4-86, and C4-95
clones (5-10 X 106 in 0.1 ml PBS) were injected intravenously (lateral vein of the tail)
into irradiated (600 rad) CBA/J or (300 rad) SLID mice. Control mice were injected with
PBS only and the mice were maintained in sterile isolators. The thymuses were removed
2, 3, or 4 wk later and the spleens were removed at various times (2, 3, 4, 6, or 8 wk).
Cell suspensions were prepared and the presence of Thy-1 .2+ and Thy-1 .1+ cells was
determined by FACS analysis using FITC-labeled Thy-1 .2 and biotin-conjugated Thy-1 .1
(plus FITC-labeled avidin)-specific mAbs. The presence of PgP-1+, L3T4+, and Lyt2+
cells in the thymocyte cell suspensions was analyzed by indirect immunofluorescence
staining using FITC-conjugated sheep anti-murine Ig antibody as a second-step reagent.
Thy-1 .1+ cells from spleen of reconstituted mice were isolated by an immunorosetting
technique using purified anti-Thy-1 .1 mAb and protein A-coupled sheep erythrocytes,
as detailed elsewhere (19), after 6-8 wk of transfer of the C4 clones. The erythrocytes in
the rosette-forming cells were lysed with ammonium-Tris chloride buffer and the viable
cells were washed three times and resuspended in CM. Aliquots ofthe cells were incubated
at 37 °C for 6-8 h, washed, and used to assess the presence of Thy-1 .1+, Thy-1 .2+, Ly-1+,
Lyt-2+, and L3T4+ cells by FACS analysis. The Thy-1 .1* cells isolated from spleen were
tested for both their proliferative response and the generation of cytotoxic T cells
stimulated by several alloantigens as follows: 3-4 X 105 Thy-1 .1 + spleen cells were
cocultured with 106 irradiated (2,200 rad) spleen cells from CBA/J, DBA/2, BALB/c,
ATH, C57BL/6, and BIO.A(4R) or with CM only, in flat-bottomed microplate wells in a
final volume of 200 ul per microwell at 37°C. Cell proliferation was assessed by [3H]-
thymidine uptake (19 .5 KBq/well) during the last 12 h of a 4-5-d culture period and
cytotoxic activity was assessed after 6 d of culture using "Cr-labeled LPS-stimulated spleen
cells from C57BL/6, BALB/c, and CBA/J mice as target cells, as described (21).
Induction oftheC4 Clones to DifferentiateIn Vitro.
￿
The C4-77, C4-86, and C4-95 clones
(3-5 X 106) suspended in 5 ml of WEHI-CM were exposed to several concentrations of
the following agents: 5-Aza (1-100 ug/ml), rIL-2 (100 and 500 U/ml), rIL-1 (10-50
U/ml), thymulin (10 ng to 10 jug/ml), PMA (10-1,000 ng/ml), retinoic acid (0.01-1
mg/ml), DMSO (0 .01-1%), and rIL-4/BSF-1 (final dilutions, 1 :4 to 1 :40). 7 ml of fresh
WEHI-CM were added to the cultures in plastic flasks 24 h later and the cultures were
incubated at 37 ° C for 1-7 d more. Aliquots of cells from the cultures were collected at
various times and the cells were assayed for expression of Thy-1 .1, Ly-1, Lyt-2, L3T4,
Ig, la, PC61, and CC 11 surface antigens by FACS analysis. The best and reproducible
results were obtained with the following protocol: the C4 clones (5 X 106) were exposed
to 5-Aza (20-25 jAg/ml) in tissue culture flasks in a final volume of 5 ml of WEHI-CM at
37°C. 24 h later, 7 ml of fresh WEHI-CM were added to the cultures and incubated at
37°C for 3 d more. After 3-5 d of culture in the absence of 5-Aza, the cells were again
treated with 5-Aza as indicated above. The cells were collected, washed, and cultured in
WEHI-CM without 5-Aza, at 2-3 X 105 cells/ml in tissue culture flasks, changing them
into fresh WEHI-CM every 2.5-3 d. In some experiments the C4 clones were treated
with 5-Aza as above and half of the cells were cultured in CM supplemented with either
rIL-2(100 U/ml) or purified IL-3 (20 U/ml) at the same culture conditions as above. The
C4 cells were collected at different times of culture and assayed for: (a) expression of
surface antigens (indicated above) by FACS analysis, and (b) proliferative responses to
cytokines as detailed above.16
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FIGURE 1 .
￿
The presence of the surface antigens indicated above on the C4-77 clone was
determined by direct or indirect immunofluorescence staining and FACS analysis . Control,
histograms from C4-77 cells stained with second-step reagent only .
Results
Development and Establishment of the Clones C4-77, C4-86, and C4-95 In Vi-
tro . We attempted to establish pro-T lymphocyte clones in vitro by using bone
marrow cells from a nu/nu mouse that containsT cell precursors but no thymus .
Most of the marrow cells belonging to other hematopoietic lineages were elimi-
nated with a mixture of mAbs plus complement treatment . These procedures
were performed to enrich for pro-T lymphocytes and to diminish possible
negative regulatory effects on growth of these cells by other marrow cells, as
encountered during the establishment of pro-B lymphocyte clones in vitro (6,
25) . The details for the establishment ofthe C4 line obtained from bone marrow
of a CBA/N X NIH Swiss II nu/nu mouse are given in Materials and Methods .
The C4 line was obtained in October 1984 and chosen for further study because
of its phenotype . Clones were obtained from this line by micromanipulation in
December 1984 . Here we report results of experiments carried out with the C4-
77, C4-86, and C4-95 clones .
Phenotypic Characteristics .
￿
The phenotype of the C4 clones was determined
by immunofluorescence staining and flow fluorocytometry (FACS) using a panel
of mAbs against surface antigens expressed by cells of the T, B, or myeloid
lineages . Fig . 1 shows the results of this analysis obtained with the C4-77 clone .
These cells have low levels of Thy-1 and Ly-1 antigens, but no detectable Lyt-2
or L3T4 T cell differentiation surface markers present on most thymocytes and
peripheral T lymphocytes from adult mice . The C4-77 cells do not carry on the
cell membrane antigens normally present on cells of the B lymphocyte (B-220,
Ig, Ia) or myeloid (GM 1 .2, Mac-1, Ia) lineages . They express the glycoproteins
detected by the PC61 mAb against IL-2-R and by the CI 1 mAb specific for IL-PALACIOS ET AL .
￿
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FIGURE 2 .
￿
Southern blot analysis of the configuration of the 0 gene complex in the C4
clones usinga 0 constant region probe (A) andaJ02-specific probe (B)and Hind III-digested
DNAs .
3-sensitive cells, which may bind to receptors for IL-3 . The C4-77 cells have high
levels of the PgP-1 glycoprotein normally present on marrow cells, fetal thymo-
cytes, and Lyt-2- L3T4- thymocytes from adult mice . The phenotype of the C4-
86 and C4-95 clones is very similar to that of the C4-77 clone .
The absence of markers normally found on cells of the B lymphocyte and/or
myeloid lineages together with the presence of the Thy-1, Ly-1, as well as the
PgP-1 glycoprotein, an antigen expressed by marrow cells that migrate to the
thymus (29), on the C4 clones raised the possibility that they could represent
earlyT cell precursors .
Configuration of the a, a, and y T Cell-specific Genes.
￿
We began to explore the
possibility that the C4-77, C4-86, and C4-95 clones could be early T cell
precursors by assessing the presence of RNA transcripts for the a, ,0, and ti T
cell genes by Northern blot analysis . We found that the three clones expressed
shorter RNA transcripts (-1.0-1 .2 kb) than the 1 .5-kb size predicted for func-
tional V+C transcripts of the 7 gene, and no transcripts for either the a or the
a genes . Next, we studied the configuration of these genes in the C4 clones by
Southern blot analysis . The presence of rearrangement of the (31 gene complex
was determined by using a cDNA constant region probe and Hind III-digested
DNA from the clones, as well as from liver. Such a combination detects a 9.5-kb
and a 3.0-kb band containing CO 1 and C02 germline elements, respectively (Fig .
2A, lane a) . These analyses show that all three C4 clones contain the COI gene
cluster in the germline configuration (Fig . 2A, lanes b-d) . The presence of
rearrangement of the 02 gene cluster in the clones was assessed by using a J02-
specific probe and Hind III-digested DNAs . The results (Fig . 2B) show that the18
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FIGURE 3.
￿
Southern blot analysis of the configuration of the a gene complex in the C4
clones using a chain-specific probes spanning 30 kb (A) and 40 kb (B) 5' to the a constant
region .
C4-77, C4-86, and C4-95 clones contain only the 5.4-kb germline band, indicat-
ing that the ,Q2 gene cluster in the C4 clones is in the germline configuration .
Owing to the distance spanning the Ja chromosomal region, rearrangement
of the a chain gene is more difficult to analyze. Nevertheless, we addressed this
issue by using a chaingene-specific genomic probes spanning 10 kb (not shown),
30 kb (Fig. 3A), and 40 kb (Fig . 3B) 5' to the a constant region, respectively,
and Bam HI- or Hpa I-digested DNAs . The results show no evidence for
rearrangements of the a chain gene complex in the C4-77, C4-86, and C4-95
clones (Fig . 3) .
The status of the y gene complex in the clones was analyzed by using acDNA
constant region probe (Fig . 4) and Eco RI-digestedDNAs . Such a combination
detects a 13.4-, a 10.5-, and a 7.5-kb band containing constant germline regions
of the 74, -y I, and y3 gene clusters, respectively, inDNA from a BALB/c mouse
(Fig . 4A); thenomenclature of they gene clusters used here is that ofTraunecker
et al . (13) . These analyses show that all three C4 clones contain the 71 and the
y4 gene clusters in the germline configuration (Fig. 4A, lanes b-d) . In addition,
these studies revealed that the mouse strains from which the C4 clones were
derived like other strains of mice (e.g., DBA/2, CBA/J, C58) (13) lack the y3
pseudogene (Fig . 4A, lanes a-d) . The same embryonic configuration of the 71
gene cluster in the C4 clones was found using a y 1 constant region-specific
probe (Fig . 4B) . We conclude that the C4-77, C4-86, and C4-95 clones contain
the a, ,3, and y T cell genes in the germline configuration and that the yRNA
transcripts detected in the C4 clones are germline transcripts .
Growth Requirements.
￿
As illustrated with the results depicted in Fig. 1, the
C4-77, C4-86, and C4-95 clones have both receptors for IL-2, and the CC11
glycoprotein, as assessed by FAGS analysis with the PC61 and theCC 11 mAbs,
respectively . We carried out immunoprecipitations from cell lysates of 125I-
labeled C4 clones with PC61 (30) or CC I I (19) mAbs and SDS-PAGE analysis .
We found that the clones express both IL-2 receptors and theCC I I glycoproteinFIGURE 4 .
￿
Southern blot analysis of the configuration of the .y gene complex in the C4
clones using cDNA-specific probes for the y constant regions (A) and -yl-specific probe (B)
and Eco RI-digested DNAs . a, liver; b, C4-77 ; c, C4-86 ; and d, C4-95 clones .
The Clones C4-77, C4-86, and C4-95 Grow in rIL-3
PALACIOS ET AL .
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Proliferative responses to the agents indicatedabove by theC4 clones were assessed by ['H]thymidine
uptake during the last 6 h of a 2-d culture period conducted at 37°C . The data are the mean of
triplicate samples (the SE in the experiment shown above was <8.6% of the mean) . IL-1 (10 U/ml),
IL-2 (100 U/ml), IL-3 (10 U/ml), GM/CSF (50 U/ml), PMA (10 ng/ml), Ionomycin (500 ng/ml).
of similar size to those precipitated by the same antibodies from IL-2-dependent
and IL-3-dependent cell lines, respectively (data not shown) .
The next set of experiments was designed to define the growth factor(s) used
by the C4 clones in vitro . Table I shows that all three C4 clones proliferated
significantly in IL-3 but not in rIL-1 or in purified GM/CSF . Saturating concen-
trations of recombinant human IL-2 promoted little DNA synthesis in the C4
clones (Table I) . However, rIL-2 did not support actual growth of the C4 clones,
i.e ., increase in number of cells, whereas rIL-3 was very effective. Table I also
shows that the combination of PMA, Ionomycin, and rIL-2 (± rIL-1), which we
previously found very effective in inducing proliferation of intrathymic T cell
precursors (21), did not increase the [3H]thymidine uptake promoted by rIL-2
Growth factors
['H]thymidine
C4-77
uptake (cpm)
C4-86
of responding cells
C4-95
None 246 74 108
rIL-1 284 91 136
rIL-2 1,372 420 510
rIL-3 15,769 16,842 8,652
GM/CSF 207 101 117
PMA + ionomycin + rIL-2 1,010 453 446
PMA + ionomycin + rIL-1 +rIL-2 929 414 25020
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FIGURE 5. The presence of
Thy-1 .1* and Thy-1 .2* cells in
thymuses from irradiated mice
that received either C4-77
cells (B), C4-86 (D), or PBS
alone (controls) (A and C) 3
wk before, was determined by
immunofluorescence staining
and FRCS analysis. C, histo-
gram from cells stained with
second-step reagent only .
alone . The data show that the growth requirements of the C4 clones are different
from those of intrathymic T cell precursors from fetal and adult mice . The C4
clones cultured in IL-3 self-renew every 12-14 h and all three clones die within
-36-48 h in the absence of IL-3 (Table I and data not shown) .
Differentiation ofthe C4 Clones.
￿
We next attempted to find out the functional
potential of the C4-77, C4-86, and C4-95 clones both in vivo and in vitro .
In Vivo Studies.
￿
One property of a putative pro-T lymphocyte should be to
home and colonize the thymus (see Introduction) . We tested the C4-77, C4-86,
and C4-95 clones for their ability to home and undergo differentiation in the
thymus of sublethally irradiated mice . We used mAbs specific for Thy-1 .1 or
Thy-1 .2 alleles and FACS analysis to distinguish cells of donor from cells of
recipient origins . The C4 clones have the potential to express both Thy-1 .1
(from NIH Swiss II) and Thy-1 .2 (from CBA/N background) alleles. Thus, we
transferred the C4 clones into irradiated mice whose T cells express Thy-1 .2
only (CBA/J) ; the presence of Thy-1 .1 ' cells in such hosts will indicate cells
generated by the C4 clones . Fig . 5 shows that thymuses from irradiated CBA/J
mice that received the C4-77 (Fig. 5B) or the C4-86 (Fig. 5D) clones 3 wk before
analysis, contained Thy-1 .1 + thymocytes, while thymuses from mice that did not
receive C4 cells (controls) contained Thy-1 .2' but not Thy-1 .1 + thymocytes (Fig .
5, A and C) . The C4-95 clone also has the property of homing and generating
Thy-1.1+ thymocytes . We have found between 13 .5 and 67.4% Thy-1.1+ C4-
derived cells in thymuses of reconstituted mice . In two experiments, the clone
C4-86 was injected into x ray-irradiated C3H/HeJ mice . The thymuses of these
mice were not repopulated despite the fact that repopulation occurred after
injection of AKR bone marrow cells. Unlike bone marrow cells, the intrathymic
injection of C4-86 cells in either CBA/J or C3H/HeJ mice never resulted in any
repopulation .
Normally the PgP-1 glycoprotein is expressed on 80-90% of fetal thymocytes
at day 14 of gestation . The proportion of PgP-1+ cells subsequently declines and
reaches adult levels (5-10%) by day 19 (29, 31, and Palacios, R., unpublishedPALACIOS ET AL.
￿
21
FIGURE 6 .
￿
The presence of the PgP-1 glycoprotein on the C4-77 (D) and C4-86 (E) clones
as well as on thymocytes from irradiated mice that received either C4-77 cells (B), C4-86 cells
(C), or PBS alone (control) (A) 3 wk before, was assessed by immunofluorescence staining and
FACS analysis . C, histograms from cells stained with second-step reagent only . RCN, relative
cell number .
results) . Using heterogenous populations of marrow cells it was found that the
cells migrating to the thymus are PgP-1' (29, 31) . Fig . 6, D and E, shows that
the C4 clones are strongly PgP-1 + before transfer into irradiated mice . Thus,
one way of assessing differentiation of the C4 clones intrathymically in vivo was
to determine the percentage of PgP-1 + cells among the Thy-1 .1' thymocytes
generated by the C4 clones in vivo (Fig. 5) . The same thymocyte cell suspensions
analyzed in the experiments shown in Fig. 3 were also tested for the presence of
PgP-1' cells by FACS analysis . The data (Fig . 6, B and C) show that there were
<10% PgP-1' cells in thymuses from mice reconstituted with the C4-77 or C4-
86 clones . A similar number of PgP-1 + cells were detected in thymuses from
irradiated mice that did not receive C4 cells (controls) (Fig. 6A) . The results
indicate that most Thy-1 .1 + thymocytes generated by the C4 clones have become
PgP-1 - , i.e ., they differentiated in vivo .
Further evidence that the C4 clones can undergo differentiation intrathymi-
cally in vivo comes from the results showing that the clones give rise to Thy-1 .1 +
thymocytes expressing Lyt-2 and L3T4 antigens (see below) . Thus, the data
indicate that the C4 clones possess the property ofhoming and differentiating in
the microenvironment of the thymus in vivo .
Next we wished to know whether the C4 clones give rise to functionally mature
peripheral T lymphocytes in vivo . Thus, we studied the spleens of irradiated
CBA/J mice that received the C4 clones 2, 3, 6, or 7 wk before, for the presence
ofThy-1 .1 + splenocytes as assessed by FACS analysis . There were no detectable
Thy-1 .1' donor-derived cells in the spleens after 2 wk and very few or none
after 3 wk of transfer, but significant numbers of Thy-1 .1' splenocytes were
detected after 6-7 wk of transfer of the C4 clones . We have found between 11
and 35% Thy-1 .1' C4 clone-derived cells in the spleens of reconstituted mice .
We have begun to study the phenotype and functions of the Thy-1 .1+ cells in
the spleen generated by the C4 clones in vivo . Thus, we isolated Thy-1 .1' cells22
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C4-derived Thy-1.1'iso-
lated responder spleen cells*
TABLE II
The C4 Clones Give Rise to Mature T Lymphocytes In Vivo
Proliferative cell responsesto ['Hlthymidine uptake (cpm)
* Thy-1.1' cells were isolated from spleens of irradiated CBA/J after 7-8 wk of transfer of the C4-
77, C4-86, or C4-95 clones. The isolated spleen cells were assayed for their phenotype by FACS
analysis as well as for their proliferative responses to the alloantigens indicated above. Cell
proliferation was determined by ['Hlthymidine uptake during the last 12 h of a 4-5-d culture
period conducted at 37°C. The data are the mean cpm of triplicate samples (the SE in the
experiments shown above was<11.4% of the mean).
from the spleens ofreconstituted mice as detailed in Materials and Methods, and
we assessed both their phenotype by FACS analysis and their capacity to prolif-
erate in response to several alloantigens . Table II shows results consistent with
the interpretation that the C4-77, C4-86, and C4-95 clones gave rise to both
Thy-1.1', Lyt-2+, L3T4-, and Thy-1.1+, Lyt-2-, L3T4' mature T lymphocytes
in vivo. Table II also shows that the isolated Thy-1 .1+ lymphocytes generated by
the C4 clones proliferated in response to alloantigens from C57BL/6, DBA/2,
ATH, BALB/c, and B10.A(4R) mice, but not to MHC antigens present on cells
from CBA/J mice in which the C4 clones underwent differentiation. In addition,
Fig. 7 shows that purified Thy-1.1' spleen cells give rise to cytotoxic T cells
specific for H-2b and H-2d alloantigens but not against H-2k MHC antigens after
stimulation in vitro with irradiated spleen cells from C57BL/6, BALB/c, and
CBA/J mice, respectively. The data indicate that the C4-77, C4-86, and C4-95
clones give rise in vivo to phenotypically and functionally mature Tlymphocytes
of different antigen specificities. In addition, the results show that the C4 clones
became tolerant to the MHC antigens present on cells of the recipient mice in
which they underwent differentiation.
Differentiation of the C4 Clones in the Environment of the SCID Mice.
￿
To further
study the potential of the C4 clones to undergo differentiation in vivo, the C4-
77 and the C4-86 clones were transferred into sublethally irradiated (300 rad)
T cell- and B cell-deficient SCID mice (18). The cells from SCID mice have the
potential to express Thy-1.2 and Lyb-2.2 surface antigens but not the Thy-1.1
or the Lyb-2.1 alleles. Thus, the presence of Thy-1.1 or Lyb-2.1 cells in
reconstituted SCID mice will indicate that the T cells or the B cell lineage cells,
respectively, were generated by the donor C4 cells. Fig. 8 shows the results of
one of the two experiments carried out showing the same phenomena. 4 wk
Clone Phenotype Medium CBA/J C57BL/6 DBA/2 ATH
C4.86 93% Thy-1.1'
49% L3T4' 2,104 2,801 33,516 53,571 47,892
43% Lyt-2'
Medium CBA/J C57BL/6 BALB/c B10.A (4R)
C4-77 91 .5% Thy-1.1'
53% L3T4' 4,814 5,613 67,920 40,391 32,973
38% Lyt-2'
C4-95 97% Thy-1.1'
56% L3T4' 5,692 7,024 52,907 45,720 51,264
39% Lyt-2'N d
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￿
Thy-1.1+ cells generated by the C4-77 and the C4-95 clones were isolated from
spleens after 8 wk of transfer of the C4 clones into irradiated CBA/J mice. Purified Thy-1.1+
(>98.5% Thy-1.1+) splenocytes were stimulated in vitro with irradiated spleen cells from
C57BL/6 (B6), BALB/c, and CBA/J mice at 37°C for 6 d and were tested for cytotoxic
activity against "Cr-labeled LPS-activated B6, BALB/c, or CBA/J splenocytes.
after transfer of the C4-77 clone into SCID mice, the thymus contained ^-2.5 X
107 cells. Virtually all of these thymic cells were Thy-1.1+ and carried on their
cell membrane the Lyt-2 and/or the L3T4 Tcell surface markers (Fig. 8A). We
found only ^-0.45 X 106 cells from the thymic rudiment of the control SCID
mice that received no C4 cells. 6 wk after transfer of the C4-77 clone into SCID
mice, we found ^-4.9-6.1 X 107 nucleated spleen cells. These populations clearly
contained Thy-1.1+, Lyt-2+, and L3T4+ T lymphocytes, but no IgM+ mature B
lymphocytes or B-220+, Lyb-2.1+ B cell precursors were detected (Fig. 8B). The
spleens from control SCID mice that received no C4 cells had <12.0 X 106
nucleated cells, which comprised <8% Thy-1.2+, 33-42% Mac-1+, and no
detectable (<1%) IgM'}, B-220+, Lyb-2.1+, L3T4+ Lyt-2+, or Thy-1.1+ cells (Fig.
8C). Similar results to those found with the C4-77 clone were obtained with the
C4-86 clone. The C4-95 clone has not yet been tested in this system. These
results provide further direct evidence that the C4 clones can generate mature
T lymphocytes but no cells of the B lymphocyte lineage in vivo.
In Vitro Studies.
￿
Due to the obvious potential to study cellular and molecular
events during differentiation from pro-T lymphocytes to mature Tlymphocytes,
we undertook the task offinding out conditions that would induce the C4 clones
to differentiate in vitro. Several agents (PMA, DMSO, retinoic acid, thymulin,
GM/CSF, rIL-1, rIL-2, rIL-3, rIL-4/BSF-1, 5-Aza) reported to induce differen-
tiation ofcells ofdifferent origins were tested. We used as readout for induction
of differentiation the expression of Lyt-2 and L3T4 surface antigens by the C4
clones as determined by FACS analysis. From all the agents tested, only the
demethylating drug 5-Aza reproducibly induced differentiation ofthe C4 clones.
Two examples illustrating these findings are shown in Fig. 9. After exposure to
5-Aza, the C4-77, C4-86, and C4-95 clones had higher levels ofThy-1 and Ly-124
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The thymus (A), and spleen (B) cells from SCID mice reconstituted with the C4-
77 clone 4 and6 wk, respectively, before analysis, and the spleen cells (C)from control SCID
mice that received no C4 cells were studied for the presence of cells bearing the cell surface
markers indicated above by immunofluorescence staining and FACS analysis. Control, cells
stained with second FITC-labeled reagentonly.
antigens and clearly expressed Lyt-2 and L3T4 antigens on their cell membrane.
The presence of the latter two surface markers on 5-Aza-treated C4 cells was
documented using three different mAbs against Lyt-2 (53-6-72 [IgG], 31688
[IgM], 3.155 [IgG]) and L3T4 (GK1.5 [IgG], RL-172 [IgM], H-129 [IgG])
antigens. None of the clones had detectable surface Ig or la antigens on their
cell membrane after 5-Aza treatment, indicating that the drug induced the C4
clones to express products of certain genes only. The differentiation of the C4
clones upon treatment with 5-Aza became detectable after 7 d, reached plateau
levels by ^-14 d, and declined 50-80 d later. As 5-Aza induced the C4 clones to
generate cellswith a phenotypesimilartothat ofthymocytes andsincethymocytes
use IL-2 but not IL-3 as growth factor in vitro, we were interested in knowing
whether 5-Aza-treated C4 cells could be switched from IL-3 to IL-2 dependence.
Thus, the C4 clones were exposed to 5-Aza and the cells were cultured and
expanded in either IL-3 or IL-2. After 21 d of culture, cells from each group
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FIGURE 9.
￿
The presence of the surface antigens indicated above on the C4 clones either
exposed (induced) or not exposed (uninduced) to 5-Aza was assessed by immunofluorescence
staining and FACS analysis.
In Vitro-induced C4-86 and C4-77 Clones Can Be Switchedfrom IL-3 to IL-2 Dependence
25
The C4 clones were treated with 5-Aza and kept in culture medium containing either rIL-2 or
purified IL-3 for 21 d. The cells were washed and tested for their proliferative responses to the
agents indicated above. Cell proliferation was measured by ['Hlthymidine uptake during the last 6 h
of a 24-h culture period. The SE of the mean of the experiment shown above was <9.3%. IL-1 (10
U/ml), IL-2 (50 U/ml), and IL-3 (10 U/ml).
were tested for their proliferative response to rIL-1, rIL-2, and rIL-3. Table III
shows that 5-Aza-treated C4-86 cells cultured in rIL-2 exhibited significant
proliferative response to IL-2, little to IL-3, and none to IL-1. In contrast, 5-
Aza-treated C4-86 cells that were cultured in IL-3 showed significant responses
to IL-3, little to IL-2, and none to IL-1. The C4-86 cells cultured in rIL-2
Responding
Clone treated
with 5-Aza
cells
Maintained in:
IL-supported
Medium
proliferation
rIL-1
['Hlthymidine
HL-2
uptake (cpm)
HL-3
C4-77 IL-2 218 316 12,627 3,518
IL-3 123 101 1,929 10,054
C4-86 IL-2 116 204 9,285 2,620
IL-3 171 192 1,634 12,77826
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FIGURE 10.
￿
The expression of surface IL-2-R and the CC11 glycoprotein on C4-86 cells
treated with 5-Azaand kept in medium containing purified IL-3 (A)or rIL-2 (B) was assessed
by immunofluorescence staining and FACS analysis usingmAbs specific for IL-2-R (7134 and
PC61)and the CCII mAb specific for IL-3-sensitive cells.
without previous treatment with 5-Aza consistently died within ^"3 d. Similar
results were obtained with the C4-77 cells. The C4-95 clone has not yet been
studied in this regard. These observations indicate that after their induction to
differentiate by 5-Aza, the C4-86 and C4-77 clones can be switched from IL-3
to IL-2 dependence in vitro. Consistent with the functional data shown in Table
111, most C4-86 and C4-77 cells exposed to 5-Aza and selected in rIL-2 had IL-
2 receptors (assessed with both 7134 and PC61 mAbs against IL-2-R by FACS
analysis) and few cells still expressed the CCII glycoprotein present on IL-3-
sensitive cells (Fig. IOB). C4-86 and C4-77 cells treated with 5-Aza and cultured
in IL-3 were both IL-2-R+ and CC11' (Fig. 10A).
We wished to know whether treatment of the C4 clones with 5-Aza followed
by selection in rIL-2 would induce them to further differentiate along the T
lymphocyte pathway. We found that C4 cells subjected to such procedures
became predominantly Thy-1+, Ly-1+, L3T4-, Lyt-2' as assessed by FACS
analysis (Fig. 11B). In several experiments performed, the C4 clones gave rise
to Lyt-2+, L3T4- cells but never to Lyt-2-, L3T4+ cells after 5-Aza treatment
and subsequent selection in IL-2 in vitro. In one experiment we isolated the Lyt-
2+, L3T4- cells generated by the C4-86 clones by cell sorting and tested them
for cytotoxic function in a lectin-facilitated cytotoxicity assay (21). We found that
they did not possess killer function (data not shown).
In the preceding section we described results of experiments aimed to char-
acterize the continuous proliferating bone marrow clones C4-77, C4-86, andC4-
95. These analyses indicate that the C4 clones do not express surface antigens
normally found on cells of the B lymphocyte or myeloid lineages and have low
levels ofThy-1 and Ly-1 antigens, but not surface markers presenton thymocytes
and peripheral T lymphocytes (Lyt-2, L3T4). They have the T cell antigenz
U
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FIGURE 11 .
￿
Theexpression of thesurface antigens indicatedby C4-86cellsthat were treated
with 5-Aza and kept in medium containing either IL-3 (A) or rIL-2 (B) was assessed by
immunofluorescence staining and FACS analysis. C, histograms of cells stained with second-
step reagent only. RCN, relative cell number.
receptor genes a and (3, as well as the T cell-specific y gene, in the germline
configuration, and express germline transcripts for the y but not for the a or
the ,8 Tcell receptorgenes. The C4 clones can homeandundergo differentiation
in the thymus and generate peripheral T lymphocytes with different antigen
specificities in vivo. Repopulation of thymuses by the C4-86 clone failed for
unknown reasons in two of twelve experiments. The C4 clones can be induced
to differentiate through the T cell pathway with 5-Aza in vitro. However, the
C4 clones did not give rise in vivo to B-220', Lyb-2+ B cell lineage cells or to
Ig+ B lymphocytes capableofgeneratingantibody-secreting cellsafter stimulation
with polyclonal B cell activators in vitro. Nor were they induced in vitro by 5-
Aza to express B cell lineage surface antigens (Ig, Ia). Moreover, the B cell
precursor-specific gene pZ183 (32) isnot expressed in the C4 clones, while Pro-
B lymphocyte clones (6) clearly expressed it (Sakaguchi, N., and R. Palacios,
unpublished results). Taken together the data indicate that the C4 clones do not
undergo differentiation along the B lymphocyte pathway either in vivo or in
vitro. Although we cannot formally exclude the possibility that their failure to
generate lymphocytes of the B cell lineage could be due to the effects of the xid
and the nude mutations on B cell development (20); it seems unlikely, because
xid/nu-defective mice do have B-220+ B cell precursors (33). Thus, the C4 clones
functionally behave as progenitors committed to the T cell lineage, i.e., pro-T
lymphocytes. The C4 clones, unlike unfractionated bone marrow cells, fail to
grow in thymuses after intrathymic injection. This finding might indicate that
they need to seed somewhere (bone marrow?) before being able to home in the
thymus. Alternatively, the C4 clones might not be representative of all T cell
precursors in the bone marrow (34).
Using bone marrow cells from mice treated with 5-fluorouracil and the site of
integration of a vector introduced by retrovirus infection as a clonal marker,
Lemischka et al. (35) failed to demonstrate the presence of lymphoid-restricted
progenitors in those marrow preparations after transfer into irradiated mice.28
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This is not surprising as it is known that early lymphoid precursors are very
sensitive cells to 5-fluorouracii treatment either in vivo or in vitro (36, 37, and
Palacios, R., unpublished observations). Thus, the use of 5-fluorouracil-treated
cell populations for the study ofearly stages oflymphocyte development can be
misleading (35-37).
The C4-77, C4-86, and C4-95 clones express IL-3-R and use IL-3 as growth
factor in vitro. Although they also express IL-2-R, these cells do not grow in the
presence ofsaturating concentrations ofrIL-2. Since it is known that IL-2 exerts
its growth-promoting activity through its high-affinity class ofreceptors (38), the
IL-2-R on the C4 clones are probably of low affinity. This is not a unique
characteristic ofthe C4 clones, since other IL-3-dependent cells were also shown
to express receptors with low affinity for IL-2 (39-41).
Interestingly, afterinduction in vitro with 5-Aza, the C4 cells could be switched
from IL-3 to IL-2 dependence. Whether 5-Aza exerts this effect on the C4 clones
by changing the affinity ofthe IL-2-R already present on these cells, by inducing
de novo expression of functional IL-2-R or by other mechanisms remains to be
determined.
The C4 clones are unresponsive to the growth factors IL-1 and GM/CSF as
they neither proliferated nor underwent differentiation in the presence of these
cytokines. It is worth stressingthe similarities and differencesin the requirements
for growth in vitro of the pro-T lymphocyte C4 clones and those of intrathymic
T cell precursors. The combination of PMA, Iono, and rIL-2 is very effective in
inducing proliferation of intrathymic Tcell precursors from fetal and adult mice
(21), but ineffective on the C4 clones (Table 1). Also, while the C4 clones express
receptors for IL-3 and grow in IL-3 in vitro, most intrathymic Tcell precursors
from fetal andadult mice exhibit neitheroftheseproperties (19, 21). Presumably,
when the pro-T lymphocyte gets into the thymus, the expression of IL-3-R is
switched off and they use IL-2 and/or IL-4/BSF-1 as their growth factor (21,
42). This view would be supported by our results showing that after induction
to differentiate with 5-Aza in vitro, the C4 cells can grow in IL-2 and most of
these cells no longer express receptors for IL-3 (Figs. 10 and 11 ; Table III).
Finally, it is interesting that both the C4 pro-T lymphocyte clones and freshly
isolated intrathymic T cell precursors proliferate in recombinant IL-4/BSF-1,
but this cytokine induces in vitro only intrathymic T cell precursors to differen-
tiate into cytolytic T cells (this study, and references 41, 42). The latter finding
could be explained by postulating that pre-T cells but not pro-T lymphocytes
(see Introduction) may be able to differentiate under the influence of IL-4/BSF-
1 in vitro. While it is clear that pro-T lymphocytes as well as pro-B lymphocyte
clones express receptors for at least three known growth factors, namely, IL-2,
IL-3, and IL-4/BSF-1, the biological significance of this is not yet understood
(41). Also, we would like to stress that not all cells grown in IL-3 and expressing
receptors for IL-2 behave as pro-T cells. Two independently derived clones of
this phenotype had no measurable pro-T cell potential.
Another finding of fundamental interest in the present study is that 5-Aza
induces the C4 clones to differentiate through the Tcell pathway in vitro. 5-Aza
induced the expression of certain genes in the C4 clones only, indicating that
not all genes in these cells are susceptible to this drug. This is not a uniquePALACIOS ET AL.
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feature of the C4 clones, as there are several reports in the literature showing
that the expression of only some genes are activated by 5-Aza in various types of
cells (reviewed in reference 43). How 5-Aza exerts its effects on the C4 clones is
not yet understood. It is known that this drug causes demethylation ofgenesand
that the state of methylation of genes correlates with their expression in many
cases (43). Possibly, demethylation ofthe inducible genes (and/or ofother genes
required for their expression) caused by 5-Aza could have activated their expres-
sion in the C4 clones. If demethylation of genes were the only mechanism of
action of 5-Aza one would expect that the expression ofmany more genes would
be induced in the C4 clones, but clearly this is not the case. It follows that there
must be a particular feature of the inducible genes that render them susceptible
to 5-Aza.
Besides proving valuable as tools for developing mAbs specific for very early
T cell precursors, the C4-77, C4-86 and C4-95 pro-T lymphocyte clones open
new and direct ways ofaddressing several questions such as: the lineage relation-
ship ofthe thymocyte subpopulations, mechanisms oftolerance to selfMHC, the
role of particular gene products in T cell development (e.g., Lyt2, L3T4, y),
what determines that a given pro-T lymphocyte gives rise to a lymphocyte with
helper or with cytotoxic function recognizing foreign antigen in the context of
class 11 and class I MHC products, respectively, and the regulation of the
expression of the T cell a, ,l, and y genes. We hope that the C4 clones will help
to answer some ofthese questions in the near future.
Summary
The continuous proliferating bone marrow clones C4-77, C4-86, and C4-95
express low levels of Thy-1 and Ly-1 surface antigens, but no detectable surface
antigens normally present on thymocytes, peripheral mature T lymphocytes,
cells of the B lymphocyte or myeloid lineages. They contain the T cell antigen
receptor genes a, #, and the Tcell-specific gene y in the germline configuration,
and they express functional receptors for IL-3 and nonfunctional receptors for
IL-2. The C4 clones are able to homeand undergo differentiation in the thymus
of sublethally irradiated mice and give rise in vivo to phenotypically and func-
tionally mature peripheral T lymphocytes displaying several antigen specificities.
In vitro 5-Azacytidine induces the C4 clones to express Lyt-2 and L3T4 Tcell
differentiation antigens, and renders them amenable to be switched from IL-3
to IL-2 dependence . However, the C4 clones seem incapable ofgiving rise to B
lymphocytes either in vivo or in vitro. They self-renew in vitro in the presence
of IL-3 every 12-14 h. We conclude that the C4 clones represent cells at the
earliest stage ofT cell development, i.e., Pro-T lymphocytes.
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